Probability of resistance evolution for exponentially growing virus in the host

被引:6
作者
Haeno, Hiroshi [1 ]
Iwasa, Yoh [1 ]
机构
[1] Kyushu Univ, Fac Sci, Dept Biol, Fukuoka 8128581, Japan
基金
日本学术振兴会;
关键词
drug resistance; virus dynamics; birth-and-death process; chemotherapy; HIV;
D O I
10.1016/j.jtbi.2007.01.009
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Chemotherapy for tumor and pathogenic virus often faces an emergence of resistant mutants, which may lead to medication failure. Here we study the risk of resistance to evolve in a virus population which grows exponentially. We assume that infected cells experience a "proliferation event" of virus at a random time and that the number of newly infected cells from an infected cell follows a Poisson distribution. Virus starts from a single infected cell and the virus infection is detected when the number of infected cells reaches a detection size. Initially virus is sensitive to a drug but later acquires resistance by mutations. We ask the probability that one or more cells infected with drug-resistant virus exist at the time of detection. We derive a formula for the probability of resistance and confirm its accuracy by direct computer simulations. The probability of, resistance increases with detection size and mutation rate but decreases with the population growth rate of sensitive virus. The risk of resistance is smaller when more cells are newly infected by viral particles from a single infected cell if the viral growth rate is the same. (c) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码:323 / 331
页数:9
相关论文
共 41 条
[1]   Stochastic interplay between mutation and recombination during the acquisition of drug resistance mutations in human immunodeficiency virus type 1 [J].
Althaus, CL ;
Bonhoeffer, S .
JOURNAL OF VIROLOGY, 2005, 79 (21) :13572-13578
[2]   The role of evolution in the emergence of infectious diseases [J].
Antia, R ;
Regoes, RR ;
Koella, JC ;
Bergstrom, CT .
NATURE, 2003, 426 (6967) :658-661
[3]   Virus dynamics and drug therapy [J].
Bonhoeffer, S ;
May, RM ;
Shaw, GM ;
Nowak, MA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (13) :6971-6976
[4]   HIV POPULATION-DYNAMICS IN-VIVO - IMPLICATIONS FOR GENETIC-VARIATION, PATHOGENESIS, AND THERAPY [J].
COFFIN, JM .
SCIENCE, 1995, 267 (5197) :483-489
[5]   EPIDEMIOLOGY OF DRUG-RESISTANCE - IMPLICATIONS FOR A POSTANTIMICROBIAL ERA [J].
COHEN, ML .
SCIENCE, 1992, 257 (5073) :1050-1055
[6]  
Feller W., 1957, INTRO PROBABILITY TH, VI
[7]  
Gallant JE, 2004, AM FAM PHYSICIAN, V70, P295
[8]   Initial therapy of HIV infection [J].
Gallant, JE .
JOURNAL OF CLINICAL VIROLOGY, 2002, 25 (03) :317-333
[9]   Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification [J].
Gorre, ME ;
Mohammed, M ;
Ellwood, K ;
Hsu, N ;
Paquette, R ;
Rao, PN ;
Sawyers, CL .
SCIENCE, 2001, 293 (5531) :876-880
[10]   TIME TO HIT HIV, EARLY AND HARD [J].
HO, DD .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (07) :450-451